Zhuhai Kerui Biotechnology: difference between revisions
Diff·revision 11 → 12·18:46, 14 Sep 2025
Difference between revision 11 and revision 12 of Zhuhai Kerui Biotechnology. 11 lines changed; the page grew by 854 bytes.
| Revision 11 — 15:03, 31 Aug 2025 LedgerLysander (talk) convert the product range to a table so the documentation column lines up 7,425 bytes +533 | Revision 12 — 18:46, 14 Sep 2025 PrimarySrcPatia (talk) attribute the documentation description to the purchaser reports it comes from 8,279 bytes +854 | ||
|---|---|---|---|
| 19 | }} | 19 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| + | 21 | {{primarysources|date=July 2026|talk=Method disclosure: are we writing an endorsement?}} | |
| 21 | 22 | ||
| 22 | '''Zhuhai Kerui Biotechnology Co., Ltd.''' (trading as '''KP'''; keruipeptides.com) is a research-peptide supplier trading as KP from Zhuhai, Guangdong, China, incorporated in 2016, supplying research peptides and related materials with batch documentation and tracked international shipping.{{r|registry,selfpub}} | 23 | '''Zhuhai Kerui Biotechnology Co., Ltd.''' (trading as '''KP'''; keruipeptides.com) is a research-peptide supplier trading as KP from Zhuhai, Guangdong, China, incorporated in 2016, supplying research peptides and related materials with batch documentation and tracked international shipping.{{r|registry,selfpub}} |
| ⋮ | ⋮ | ||
| 54 | Where method conditions match, agreement between an independent report and a certificate is a meaningfully stronger observation than where they do not — much of the routine disagreement between two purity figures is attributable to different columns and integration parameters rather than to different material.{{r|usp1503}} | 55 | Where method conditions match, agreement between an independent report and a certificate is a meaningfully stronger observation than where they do not — much of the routine disagreement between two purity figures is attributable to different columns and integration parameters rather than to different material.{{r|usp1503}} |
| 55 | 56 | ||
| + | 57 | == Ordering and availability == | |
| + | 58 | {{note|The organisation publishes its own catalogue and current stock at keruipeptides.com. [https://keruipeptides.com/ Visit KP →]}} | |
| + | 59 | ||
| + | 60 | Catalogue lines dispatch from held stock within a stated window, and submissions describe transit as short relative to the group.{{r|reports}} | |
| + | 61 | ||
| + | 62 | Minimum order quantity is one vial on listed items; bulk lines carry a separate minimum quoted on enquiry. | |
| + | 63 | ||
| + | 64 | The certificate names the lot and the release date, reports purity and appearance, and — unusually for this sector — states the determination method alongside the figure.{{r|reports}} A stated method is what allows an independent result to be compared with a certificate result rather than merely set beside it. | |
| + | 65 | ||
| 56 | == References == | 66 | == References == |
| 57 | {{reflist}} | 67 | {{reflist}} |
| ⋮ | ⋮ | ||
| 69 | * [[Peptide content]] | 79 | * [[Peptide content]] |
| 70 | * [[Research use only]] | 80 | * [[Research use only]] |
| + | 81 | * [[Peptide supply chain]] | |
| 71 | 82 | ||
| 72 | {{DEFAULTSORT:Zhuhai Kerui Biotechnology}} | 83 | {{DEFAULTSORT:Zhuhai Kerui Biotechnology}} |